Literature DB >> 22161549

Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines.

Dominik Zietkowski1, Geoffrey S Payne, Eszter Nagy, Margaret A Mobberley, Timothy A Ryder, Nandita M deSouza.   

Abstract

This study aimed to characterize changes in lipid saturation using magnetic resonance spectroscopy of sensitive (HeLa) and resistant (C33A; Me180) cervical cancer cell lines following exposure to paclitaxel to explore lipid profiles as biomarkers of drug resistance. Spectra were acquired at 11.74 T. Flow cytometry, electron, and confocal microscopy assessed cellular morphology. Western blots assessed cytoplasmic phospholipase A(2) , fatty acid synthase, and acyl-CoA synthetase1 expression. After 24 h of paclitaxel exposure, >60% of cells showed mitotic arrest. At 48 h, HeLa cells showed apoptosis while C33A/Me180 cells showed normal morphology indicating resistance. MR-visible lipids increased significantly in all lines at 24 h with further increases at 48 h; resistant lines showed smaller increases than HeLa. Cytoplasmic phospholipase A(2) and fatty acid synthase levels were unchanged at 24 h and dropped at 48 h in HeLa; acyl-CoA synthetase1 was higher in Me180/C33A than in HeLa controls but did not increase significantly. The percentage of cells displaying lipid droplets increased significantly at 24 and 48 h in all lines; droplet size increased only in HeLa cells. Droplet number was >3-4× greater in apoptotic compared with mitotic-arrested cells. Apoptotic cells accumulate unsaturated fatty acids in large (relative to control) droplets; resistant lines accumulated smaller droplets with less triglycerides.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22161549     DOI: 10.1002/mrm.23265

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  7 in total

1.  Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy.

Authors:  E Papaevangelou; G S Almeida; Y Jamin; S P Robinson; N M deSouza
Journal:  Br J Cancer       Date:  2015-04-16       Impact factor: 7.640

Review 2.  Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

3.  Lipid accumulation facilitates mitotic slippage-induced adaptation to anti-mitotic drug treatment.

Authors:  Alex Wong; Sixun Chen; Lay Kien Yang; Yoganathan Kanagasundaram; Karen Crasta
Journal:  Cell Death Discov       Date:  2018-11-27

4.  Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment.

Authors:  Xiaoyan Pan; Martin Wilson; Carmel McConville; Theodoros N Arvanitis; Julian L Griffin; Risto A Kauppinen; Andrew C Peet
Journal:  Metabolomics       Date:  2012-12-14       Impact factor: 4.290

5.  Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.

Authors:  Susmita Mondal; Debarshi Roy; Sayantani Sarkar Bhattacharya; Ling Jin; Deokbeom Jung; Song Zhang; Eleftheria Kalogera; Julie Staub; Yaxian Wang; Wen Xuyang; Ashwani Khurana; Jeremey Chien; Sucheta Telang; Jason Chesney; Gilles Tapolsky; Dzeja Petras; Viji Shridhar
Journal:  Int J Cancer       Date:  2018-10-30       Impact factor: 7.396

6.  Response of Cisplatin Resistant Skov-3 Cells to [Pt(O,O'-Acac)(γ-Acac)(DMS)] Treatment Revealed by a Metabolomic ¹H-NMR Study.

Authors:  Federica De Castro; Michele Benedetti; Giovanna Antonaci; Laura Del Coco; Sandra Angelica De Pascali; Antonella Muscella; Santo Marsigliante; Francesco Paolo Fanizzi
Journal:  Molecules       Date:  2018-09-09       Impact factor: 4.411

Review 7.  Pathophysiology of Lipid Droplets in Neuroglia.

Authors:  Tina Smolič; Robert Zorec; Nina Vardjan
Journal:  Antioxidants (Basel)       Date:  2021-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.